Which patients benefit most from stereotactic body radiotherapy or surgery in medically operable non‐small cell lung cancer? An in‐depth look at patient characteristics on both sides of the debate

The role of stereotactic body radiotherapy (SBRT) in early stage medically operable non‐small cell lung cancer is currently under debate. SBRT's advantage is its ability to provide high radiotherapy doses to a tumor in a short timeframe, without the risk of postoperative complications and morta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Gail Wan Ying, Chua, Kevin Lee Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775005/
https://www.ncbi.nlm.nih.gov/pubmed/31389163
http://dx.doi.org/10.1111/1759-7714.13160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775005/
https://www.ncbi.nlm.nih.gov/pubmed/31389163
http://dx.doi.org/10.1111/1759-7714.13160

Ejemplares similares